Novartis Ag NVS
NYSE NVS
$141.95 -0.63 (-0.44%)
As of: Oct 1, 2026 · 11:44 AM EDT

Novartis Ag (NVS) Receivables - Other (2016 - 2024)

Updated

Novartis Ag's Receivables - Other came in at $1.33 billion for Q4 2024, up 6.1% from $1.25 billion a year earlier.

Analysis

Novartis Ag (NVS) Receivables - Other (2016 - 2024) Analysis & Trends

Going back to Q4 2016, Novartis Ag's Receivables - Other data covers 9 quarters.

  • Receivables - Other has increased in each of the last three years, with a five-year compound annual growth rate of 2.7% (FY2019 to FY2024).
  • Going back by year, Receivables - Other was $1.25 billion in FY2023 (+30.7%), $958 million in FY2022 (+20.8%), $793 million in FY2021 (-17.7%) and $963 million in FY2020 (-17.3%).
  • The Q4 2024 figure represents the highest quarterly Receivables - Other since Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Bristol Myers Squibb 127.55 Bn 78.82 Bn 9.25 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 1.33 Bn
Dec 31, 2023 1.25 Bn
Dec 31, 2022 958.00 Mn
Dec 31, 2021 793.00 Mn
Dec 31, 2020 963.00 Mn
Dec 31, 2019 1.17 Bn
Dec 31, 2018 1.36 Bn
Dec 31, 2017 1.03 Bn
Dec 31, 2016 1.03 Bn
API Access

Novartis Ag Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=NVS&period=max&api_key=YOUR_API_KEY